Concepedia

Open-Label Amantadine in Children with Attention-Deficit/Hyperactivity Disorder

Renato Donfrancesco, Dario Calderoni, Benedetto Vitiello

Journal of Child and Adolescent Psychopharmacology · 2007 · 20 citations · 32 references

DOI

Abstract

These data suggest that amantadine has acceptable acute tolerability at single doses up to 150 mg/day and is possibly efficacious in decreasing ADHD symptoms, although its activity appears to be more modest than that of stimulant medications.

References

32

Statistical power analysis for the behavioral sciences

Computers Environment and Urban Systems · 1990 · 65.6K citations

, , +4

Clinical Relevance of the Primary Findings of the MTA: Success Rates Based on Severity of ADHD and ODD Symptoms at the End of Treatment

James M. Swanson, Helena C. Kraemer, Stephen P. Hinshaw et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 2001 · 1.1K citations

, , +13

Atomoxetine in the Treatment of Children and Adolescents With Attention-Deficit/Hyperactivity Disorder: A Randomized, Placebo-Controlled, Dose-Response Study

David Michelson, Douglas E. Faries, Joachim Wernicke et al. · PEDIATRICS · 2001 · 668 citations

A Placebo-Controlled Study of Guanfacine in the Treatment of Children With Tic Disorders and Attention Deficit Hyperactivity Disorder

Phillip Chappell, Y S Kim, Robert T. Schultz et al. · American Journal of Psychiatry · 2001 · 581 citations

Comparison of Diagnostic Criteria for Attention-Deficit Hyperactivity Disorder in a County-Wide Sample

Mark L. Wolraich, Jane N. Hannah, Theodora Y. Pinnock et al. · Journal of the American Academy of Child & Adolescent Psychiatry · 1996 · 557 citations

, , +10